Publication Name	World Journal of Stem Cells
Manuscript ID	11414
Country	United Kingdom

Received	2014-05-20 08:27
Peer-Review Started	2014-05-20 21:15
To Make the First Decision	2014-06-06 11:01
Return for Revision	2014-06-16 11:30
Revised	2014-08-01 16:54
Second Decision	2014-09-01 15:16
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-09-01 15:21
Articles in Press	2014-09-01 15:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-15 12:56
Publish the Manuscript Online	2014-09-25 12:31

ISSN	1948-0210 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Orthopedics
Manuscript Type	Clinical Trials Study
Article Title	Ability of bone graft substitutes to support the osteoprogenitor cells: An in-vitro study
Manuscript Source	Invited Manuscript
All Author List	Ziad Dahabreh, Michalis Panteli, Ippokratis Pountos, Mark Howard, Peter Campbell and Peter V Giannoudis
Funding Agency and Grant Number	Funding Agency Grant Number Educational grant by Smith and Nephew
Corresponding Author	Peter V Giannoudis, BSc, MB, MD, FRCS, Professor, Academic Department of Trauma and Orthopaedics, School of Medicine, University of Leeds, Great George Street, LS1 3EX, Leeds, United Kingdom. pgiannoudi@aol.com
Key Words	Bone graft; Bone graft substitute; Osteoprogenitor cells; Fracture healing; Bone
Core Tip	Various commercially available bone graft substitutes (BGS) exist today and are used for the restoration of bone defects resulting from traumatic injury, tumor resection and congenital or degenerative diseases. Such BGS should pose osteoinductive and osteoconductive properties and support cell response to the osteogenic signalling. This study evaluated seven commercially available BGS in terms of osteoprogenitor cell adherence, proliferation and osteogenic differentiation. ?-tricalcium phosphate was found to have the most favourable effect on cell viability and allow for their subsequent proliferation and differentiation.
Publish Date	2014-09-25 12:31
Citation	Dahabreh Z, Panteli M, Pountos I, Howard M, Campbell P, Giannoudis PV. Ability of bone graft substitutes to support the osteoprogenitor cells: An in-vitro study. World J Stem Cells 2014; 6(4): 497-504
URL	http://www.wjgnet.com/1948-0210/full/v6/i4/497.htm
DOI	http://dx.doi.org/10.4252/wjsc.v6.i4.497

Full Article (PDF)	WJSC-6-497.pdf
Full Article (Word)	WJSC-6-497.doc
Manuscript File	11414-Review.docx
Answering Reviewers	11414-Answering reviewers.pdf
Biostatistics Review Certificate	Biostatistician_Review_Report_20140520055451.pdf
Copyright License Agreement	11414-Copyright assignment.pdf
Peer-review Report	11414-Peer review(s).pdf
Scientific Misconduct Check	11414-CrossCheck.jpg
Scientific Editor Work List	11414-Scientific editor work list.pdf